Abstract
Although it is known that obesity increases the risk of endometrial cancer and is linked to higher mortality rates in the general population, the association between obesity and mortality among endometrial cancer survivors is unclear. We performed a medline search using exploded Mesh keywords ‘endometrial neoplasms/’ and (‘body mass index/’ or ‘obesity/’) and (‘survival analysis/’ or ‘mortality/’ or (survivor* or survival*).mp.). We also inspected bibliographies of relevant papers to identify related publications. Our search criteria yielded 74 studies, 12 of which met inclusion criteria. Four of the included studies reported a statistically or marginally significant association between obesity and higher all cause mortality among endometrial cancer survivors after multivariate adjustment. The suggestive association between body mass index and higher all cause mortality among women with endometrial cancer was comparable to the magnitude of association reported in prospective studies of healthy women. Of the five studies that examined progression-free survival and the two studies reporting on disease-specific mortality, none reported an association with obesity. Future studies are needed to understand disease-specific mortality, the importance of obesity-onset timing and whether mechanisms of obesity-related mortality in this population of women differ from those of the general population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
National Cancer InstituteEndometrial Cancer. In: What You Need to Know About Cancer of the Uterus. National Cancer Institute: Bethesda, 2012.
Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011. CA Cancer J Clin 2011; 61: 212–236.
Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O . Lifestyle and endometrial cancer risk: a cohort study from the Swedish twin registry. Int J Cancer 1999; 82: 38–42.
Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 2011; 43: 451–454.
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I . Endometrial cancer. Lancet 2005; 366: 491–505.
Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ . Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 2004; 92: 789–793.
Jemal A, Siegel R, Xu J, Ward E . Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277–300.
Fader AN, Arriba LN, Frasure HE, von Gruenigen VE . Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114: 121–127.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625–1638.
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D . Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW . Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097–1105.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763–778.
McTiernan A, Irwin M, Vongruenigen V . Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 2010; 28: 4074–4080.
Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L et al. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 2009; 200: 288.e1–288.e8.
Moher D, Liberati A, Tetzlaff J, Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Medicine: A Peer-Reviewed, Independent, Open-Access Journal 2009; 3: e123–e130.
Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM . Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 2007; 17: 441–446.
Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH et al. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol 2007; 105: 59–65.
Mauland KK, Trovik J, Wik E, Raeder MB, Njolstad TS, Stefansson IM et al. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. Br J Cancer 2011; 104: 921–926.
von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR . Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma. Cancer 2006; 107: 2786–2791.
Gates EJ, Hirschfield L, Matthews RP, Yap OWS . Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc 2006; 98: 1814.
Anderson B, Connor JP, Andrews JI, Davis CS, Buller RE, Sorosky JI et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol 1996; 174: 1171–1178 ; discussion 1178–1179.
Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2003; 90: 150–157.
Jeong NH, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 2010; 118: 24–28.
Kodama J, Seki N, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y . Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women. Int J Gynaecol Obstet 2005; 91: 151–156.
Temkin SM, Pezzullo JC, Hellmann M, Lee YC, Abulafia O . Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol 2007; 30: 8–14.
Munstedt K, Wagner M, Kullmer U, Hackethal A, Franke FE . Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control 2008; 19: 909–916.
Studzinski Z, Zajewski W . Factors affecting the survival of 121 patients treated for endometrial carcinoma at a Polish hospital. Arch Gynecol Obstet 2003; 267: 145–147.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.
Foley K, Lee RB . Surgical complications of obese patients with endometrial carcinoma. Gynecol Oncol 1990; 39: 171–174.
Villareal DT, Apovian CM, Kushner RF, Klein S . Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the obesity society. Am J Clin Nutr 2005; 82: 923–934.
Calle EE, Kaaks R . Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–591.
Kaaks R, Lukanova A, Kurzer MS . Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531–1543.
Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P . Role of exogenous and endogenous hormones in endometrial cancer. Ann NY Acad Sci 2001; 943: 296–315.
Blanchard CM, Courneya KS, Stein K . Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol 2008; 26: 2198–2204.
Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 2005; 97: 422–430.
Lynch BM . Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol Biomarkers Prev 2010; 19: 2691–2709.
Moore SC, Gierach GL, Schatzkin A, Matthews CE . Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 2010; 103: 933–938.
von Gruenigen VE, Courneya KS, Gibbons HE, Kavanagh MB, Waggoner SE, Lerner E . Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. Gynecol Oncol 2008; 109: 19–26.
Sorosky JI . Endometrial cancer. Obstet Gynecol 2008; 111 (2 Pt 1): 436–447.
Acknowledgements
This work was supported in part by the training grant T32 CA105666.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Arem, H., Irwin, M. Obesity and endometrial cancer survival: a systematic review. Int J Obes 37, 634–639 (2013). https://doi.org/10.1038/ijo.2012.94
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2012.94
Keywords
This article is cited by
-
Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis
BMC Cancer (2022)
-
Patient-initiated follow-up of early endometrial cancer: a potential to improve post-treatment cardiovascular risk?
Archives of Gynecology and Obstetrics (2022)
-
Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer
International Journal of Clinical Oncology (2022)
-
Socioeconomic disparities in endometrial cancer survival in Germany: a survival analysis using population-based cancer registry data
Journal of Cancer Research and Clinical Oncology (2022)
-
Cancer survivorship, excess body fatness and weight-loss intervention—where are we in 2020?
British Journal of Cancer (2021)